Objective: In a budget-constrained health care system, decisions regarding resource allocation towards research and implementation are critical and can be informed by cost-effectiveness analysis. The objective of this study was to assess the societal value of conducting further research to inform reimbursement decisions and implementation of cost-effective psychotherapy for clusters B and C personality disorders (PDs). Methods: Value of information and value of implementation analyses were conducted using previously developed cost-effectiveness models for clusters B and C PDs to evaluate the parameters that contribute to most of the decision uncertainty, and to calculate the population expected values of perfect information (pEVPI) and perfect implementation (pEVPIM). Results: The pEVPI was estimated to be €425 million for cluster B PDs and €315 million for cluster C PDs, indicating that gathering additional evidence is expected to be cost-effective. The categories of parameters for which reduction of uncertainty would be most valuable were transition probabilities and health state costs. The pEVPIM was estimated to be €595 million for cluster B PDs and €1,372 million for cluster C PDs, suggesting that investing in implementation of cost-effective psychotherapy is likely to be worthwhile. Conclusions: The societal value of additional research on psychotherapy for clusters B and C PDs is substantial, especially when prioritizing information on transition probabilities and health state costs. Active implementation of cost-effective treatment strategies into clinical practice is likely to improve the efficiency of health care provision in The Netherlands. Copyright

Additional Metadata
Keywords Bayesian analysis, Cost-effective psychotherapy, Health care decision making, Value of implementation, Value of information
Persistent URL dx.doi.org/10.1016/j.jval.2010.10.020, hdl.handle.net/1765/34236
Citation
Soeteman, D.I, van Busschbach, J.J, Verheul, R, Hoomans, T, & Kim, J.J. (2011). Cost-effective psychotherapy for personality disorders in the Netherlands: The value of further research and active implementation. Value in Health, 14(2), 229–239. doi:10.1016/j.jval.2010.10.020